Dr. Reddy's Laboratories Limited
RDY
$13.94
-$0.28-1.97%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 998.56M | 982.71M | 989.56M | 957.01M | 919.78M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 998.56M | 982.71M | 989.56M | 957.01M | 919.78M |
| Cost of Revenue | 430.32M | 436.67M | 408.84M | 386.72M | 364.22M |
| Gross Profit | 568.24M | 546.03M | 580.72M | 570.29M | 555.56M |
| SG&A Expenses | 299.70M | 277.91M | 285.52M | 274.67M | 272.01M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -9.10M | -16.15M | -5.10M | -6.61M | -5.43M |
| Total Operating Expenses | 793.89M | 782.28M | 768.08M | 741.58M | 705.04M |
| Operating Income | 204.67M | 200.42M | 221.48M | 215.43M | 214.73M |
| Income Before Tax | 222.58M | 231.69M | 221.88M | 228.82M | 225.62M |
| Income Tax Expenses | 57.86M | 48.32M | 55.69M | 68.67M | 58.75M |
| Earnings from Continuing Operations | 164.72M | 183.37M | 166.19M | 160.15M | 166.87M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 958.20K | 762.50K | 1.12M | -10.29M | -- |
| Net Income | 165.68M | 184.13M | 167.32M | 149.86M | 166.87M |
| EBIT | 204.67M | 200.42M | 221.48M | 215.43M | 214.73M |
| EBITDA | 260.36M | 238.61M | 277.35M | 262.88M | 260.41M |
| EPS Basic | 0.20 | 0.22 | 0.20 | 0.18 | 0.20 |
| Normalized Basic EPS | 0.16 | 0.17 | 0.17 | 0.16 | 0.16 |
| EPS Diluted | 0.20 | 0.22 | 0.20 | 0.18 | 0.20 |
| Normalized Diluted EPS | 0.16 | 0.17 | 0.17 | 0.16 | 0.16 |
| Average Basic Shares Outstanding | 832.04M | 833.19M | 833.31M | 832.98M | 832.54M |
| Average Diluted Shares Outstanding | 833.02M | 834.07M | 834.30M | 834.09M | 834.03M |
| Dividend Per Share | -- | 0.09 | -- | -- | -- |
| Payout Ratio | -- | 0.00% | 0.00% | 53.07% | -- |